LAB — STANDARD BIOTOOLS INC

Ownership history in MAK CAPITAL ONE LLC  ·  4 quarters on record

This page tracks every 13F SEC filing in which MAK CAPITAL ONE LLC reported a position in STANDARD BIOTOOLS INC (LAB). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
3.18% (2025 Q3)
Avg. % of fund
1.84%
First filed
2025 Q1
Last filed
2025 Q4
Quarters held
4
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 ADDED 19,288,158 +3,356,352 +21.1% 2.72% $24.7M $1.28
2025 Q3 ADDED 15,931,806 +10,334,384 +184.6% 3.18% $20.7M $1.30
2025 Q2 ADDED 5,597,422 +2,822,701 +101.7% 0.96% $6.7M $1.20
2025 Q1 INITIATED 2,774,721 — — 0.51% $3.0M $1.08
% of Fund (quarterly)    LAB price (monthly, adj. close)

Other funds also holding LAB

As of 2025 Q4 — sorted by position size

Casdin Capital, LLC 3Y 7Y 7.06% Nan Fung Group Holdings Ltd 3Y 2.16% Hollow Brook Wealth Management LLC 3Y 7Y 1.84% Tikvah Management LLC 3Y 7Y 1.21% Long Focus Capital Management, LLC 3Y 0.43% QVIDTVM Management LLC 3Y 0.33% VIKING GLOBAL INVESTORS LP 3Y 7Y 0.2% Intellectus Partners, LLC 3Y 7Y 0.1% JOHNSON & JOHNSON 3Y 0.07% Amova Asset Management Americas, Inc. 3Y 7Y 0.06%
← Back to MAK CAPITAL ONE LLC Holdings